bit.bio

Developer of a cell coding technology designed for a new generation of cell therapies by democratizing access to consist

Biotechnology 📍 Cambridge, United Kingdom Founded 2016

Current Valuation

$739.42M

as of 2021-Q4

PRIVATE

Developer of a cell coding technology designed for a new generation of cell therapies by democratizing access to consistent and functional human cells.

Company Profile

Founded

2016

Cambridge, United Kingdom

Employees

164

Total Raised

$250.32M

Last Round

Series B — $187.51M (Dec 2021)

IPO Status

private

Fundraising Status

Series B · $187.51M · 4y 8mo ago

privateTotal raised $250.32M

Latest Funding Round

Round	Amount	Date	Lead Investor	Post-Money
Series B	$187.51M	Dec 2021	—	$739.42M

Health CareBiotechnologyCommercial

Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.